EMEA-001523-PIP03-18-M01

Table of contents

Key facts

Invented name
Tremfya
Active substance
guselkumab
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0250/2021
PIP number
EMEA-001523-PIP03-18-M01
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of chronic idiopathic arthritis (including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and juvenile idiopathic arthritis)
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Janssen-Cilag International NV

E-mail: contact@janssen-emea.com
Tel. +32 1460 2111

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating